Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Drug GMP Dispute Resolution Guidance Allows 10 Days For Objections

This article was originally published in The Tan Sheet

Executive Summary

FDA's dispute resolution pilot will allow manufacturers 10 days to challenge FDA inspection findings
Advertisement

Related Content

Dispute resolution guidance
Dispute resolution guidance
Dispute resolution guidance
New Quality Assessment Office Will Enhance CMC Review Efficiency – Winkle
New Quality Assessment Office Will Enhance CMC Review Efficiency – Winkle
New Quality Assessment Office Will Enhance CMC Review Efficiency – Winkle
GMP Dispute Resolution Pilot To Cover Scientific And Technical Issues Only
FDA Will Propose Drug GMP Quality Management Systems By December
GMP Dispute Resolution Pilot Proposed To Evaluate Three-Stage Process
GMP Dispute Resolution Pilot Proposed To Evaluate Three-Stage Process

Topics

Advertisement
UsernamePublicRestriction

Register

PS095896

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel